Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.

Literature DB >> 6207850

A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.

G Champault, J C Patel, A M Bonnard.

Abstract

Entities: Disease Species

Mesh：

Substances：
Plant Extracts

Year: 1984 PMID： 6207850 PMCID： PMC1463641 DOI： 10.1111/j.1365-2125.1984.tb02491.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

6 in total

1. Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.

Authors: P K Siiteri; J D Wilson
Journal: J Clin Invest Date: 1970-09 Impact factor: 14.808

2. Inhibition of androgen metabolism and binding by a liposterolic extract of "Serenoa repens B" in human foreskin fibroblasts.

Authors: C Sultan; A Terraza; C Devillier; E Carilla; M Briley; C Loire; B Descomps
Journal: J Steroid Biochem Date: 1984-01 Impact factor: 4.292

3. The possible mechanism of protection induced by dexamethasone against sudden death due to coronary ligation in conscious rats.

Authors: M Koltai; I Leprán; G Nemecz; L Szekeres
Journal: Br J Pharmacol Date: 1983-06 Impact factor: 8.739

Review 4. The pathogenesis of benign prostatic hyperplasia.

Authors: J D Wilson
Journal: Am J Med Date: 1980-05 Impact factor: 4.965

5. Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues.

Authors: G L Hammond
Journal: J Endocrinol Date: 1978-07 Impact factor: 4.286

6. Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate.

Authors: E Carilla; M Briley; F Fauran; C Sultan; C Duvilliers
Journal: J Steroid Biochem Date: 1984-01 Impact factor: 4.292

6 in total

17 in total

1. A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.

Authors: Fatih Hizli; M Cemil Uygur
Journal: Int Urol Nephrol Date: 2007-01-04 Impact factor: 2.370

2. Randomized double-blind controlled clinical trials with herbal preparations of Serenoa repens fruits in treatment of lower urinary tract symptoms : An overview.

Authors: Rainer C Görne; Tankred Wegener; Olaf Kelber; Björn Feistel; Jürgen Reichling
Journal: Wien Med Wochenschr Date: 2016-11-29

Review 3. Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.

Authors: G L Plosker; R N Brogden
Journal: Drugs Aging Date: 1996-11 Impact factor: 3.923

4. Distribution study of radioactivity in rats after oral administration of the lipido/sterolic extract of Serenoa repens (Permixon) supplemented with [1-14C]-lauric acid, [1-14C]-oleic acid or [4-14C]-beta-sitosterol.

Authors: G Chevalier; P Benard; H Cousse; T Bengone
Journal: Eur J Drug Metab Pharmacokinet Date: 1997 Jan-Mar Impact factor: 2.441

5. In vitro inhibition of testicular delta 5-3 beta-hydroxysteroid dehydrogenase and prostatic 5 alpha-reductase activities in rats and humans by strogen forte extract.

Authors: I Tóth; M Szécsi; J Julesz; I Faredin; B Behnke
Journal: Int Urol Nephrol Date: 1996 Impact factor: 2.370